The December issue features:
herpes zoster (shingles) immunisation programme 2017 to 2018: evaluation report
Pertussis vaccination programme for pregnant women update
human papillomavirus (HPV) vaccination coverage in adolescent females in England: 2017to 2018 report
The Falsified Medicines Directive (FMD) as it applies to centrally supplied vaccines for the national immunisation programme
Fluenz Tetra ordering in England
supply of UK-licensed BCG vaccine manufactured by AJ Vaccines (formerly the Statens Serum Institut (SSI)) for the national BCG programme
fundamentals of Immunisation - places still available
The Vaccine Damage Payment Scheme (VDPS) provides a single, tax-free payment. A decision to offer vaccine should be based upon the recommendations in the Green Book and should not be influenced by a vaccine’s eligibility for a VDPS settlement.
Letter. We report an infant case of meningococcal group W meningitis presenting within 24 hours of receiving group B meningococcal vaccine (4CMenB), illustrating the dilemma clinicians face in interpreting advice for management of post-immunisation fever and the National Institute for Health and Care Excellence (NICE) fever guidelines, and highlighting the need for sustained vigilance for bacterial infections in infants with post-4CMenB fever.. To read the full article, log in using your NHS OpenAthens details.
The risk of all-cause and cardiovascular death in patients with heart failure is reduced by almost one fifth in those having annual flu vaccinations compared with non-vaccinated patients, a Danish cohort study has found. To read the full article, log in using your NHS OpenAthens details.
A new large-scale study looks at the link between infant immunisation and developmental checks attendance, and emergency hospital admissions in childhood. Dorothy Lepkowska shares the research's findings. To read the full article, log in using your MPFT NHS OpenAthens details
This document is for healthcare professionals administering or providing advice about the rotavirus vaccine. It includes the vaccination programme recommendations, contraindications, precautions and examples of scenarios that staff may experience when immunising.
This letter is intended to give providers of seasonal flu immunisation and other stakeholders, preliminary information on the recommended vaccines for the 2019 to 2020 seasonal flu vaccination programme.
This leaflet includes:
the MMR booster
the diphtheria, tetanus, pertussis and polio booster
the annual childhood nasal flu programme
revised routine immunisation schedule and selective immunisation schedule from Autumn 2018
This study supports earlier studies that the MMR vaccine has no link with the risk of autism.
It follows a 2014 review that pooled the results of 10 observational studies on childhood vaccine and found no evidence of any link between the MMR vaccine and autism.
The strength of this study is that it follows a large number of children. This makes the findings more reliable when assessing a fairly rare outcome like autism, and reduces the possibility that the findings are down to chance.
News from our partners Public Health England
Public Health England (PHE) in the West Midlands is calling for students to get the MenACWY vaccine as cases of meningococcal disease – that can lead to meningitis and septicaemia (blood poisoning) – are anticipated to spike in the winter months.
All teenagers aged 18 and 19 (born between 1 September 1996 and 31 August 1997) are eligible to receive the vaccine for free, regardless of whether they’re studying or pursuing other activities.
PHE figures show that cases of meningococcal disease peak each year during winter – December through to March.
JUST FOUR IN 10 PREGNANT WOMEN ACCEPTED the offer of flu vaccination during the 2014/15 winter season.
The low take up is despite figures showing that 36 pregnant women died from certain strains of flu in the UK and Ireland between 2009-12, accounting for one in 11 of all maternal deaths during this period. To read the full article, log in using your NHS Athens